Related Experiment Videos
[The role of the platelet-activating factor (PAF-acether) in renal pathology]
1Institut Henri Beaufour, Les Ulis.
Presse Medicale (Paris, France : 1983)
|April 16, 1988
Abstract:
Platelet activating factor (PAF-acether) is emerging as a potentially crucial mediator of kidney physiopathology. Several experimental studies indicate that the mediator is implicated, directly or via other agonists, in several renal diseases.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity.
Journal of lipid mediators and cell signalling·1996
Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1996
Role of platelet activating factor in kidney transplant rejection in the rat.
Kidney international·1995
Platelet-activating factor stimulates gastric acid secretion in isolated rabbit gastric glands.
The American journal of physiology·1995
Effect of limonene and sobrerol on monocrotaline-induced lung alterations and pulmonary hypertension.
International archives of allergy and immunology·1995
Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.
Presse medicale (Paris, France : 1983)·2026
Artificial intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.
Presse medicale (Paris, France : 1983)·2026
AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.
Presse medicale (Paris, France : 1983)·2026
Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.
Presse medicale (Paris, France : 1983)·2026
Ethical, legal, and regulatory challenges in AI-based healthcare tools.
Presse medicale (Paris, France : 1983)·2026
Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.
Presse medicale (Paris, France : 1983)·2026
Bioactive Constituents of Piper crocatum Ruiz & Pav. and Piper betle Linn. as Antifungal and Antibiofilm Agents Against Candida albicans.
Drug design, development and therapy·2026
Divergent Syntheses of Euphorbia Diterpenoids: A Relay Rearrangement Strategy Triggered by Pyridinium Ring Contraction.
Journal of the American Chemical Society·2026
A Repurposed S-Adenosyl-l-Methionine Synthetase Mediates Cytidyl-Cyclitol Natural Product Assembly.
Journal of the American Chemical Society·2026
Small-Molecule-Directed RNA Modification via Proximity-Driven Catalysis.
Journal of the American Chemical Society·2026